News

News stories

Professor Dame Pamela Shaw
Professor Dame Pamela Shaw

World-renowned MND researcher and clinician says making research easier to understand, and showing why it matters, is vital

One of the world’s leading scientists on motor neurone disease (MND) and other neurological diseases says making complex research more accessible and understandable is vital to show progress is being made at developing treatments for the conditions.
DNA strand

FDA approves trial to advance pioneering treatment for Hereditary Spastic Paraplegia (HSP)

The US Food and Drug Administation (FDA) has approved BlackfinBio Limited’s Phase 1/2 clinical trial for its novel adeno-associated virus (AAV) gene therapy targeting Hereditary Spastic Paraplegia (HSP) Type 47 (SPG47).
DNA strands

ΞΆΓάΘ¦ spinout takes major step towards advancing pioneering treatments for Hereditary Spastic Paraplegia (HSP)

BlackfinBio Limited is a spinout company from the University of ΞΆΓάΘ¦ set to pioneer novel therapies for rare genetic neurological diseases.

Image of motor neurones

Groundbreaking EXPERTS-ALS study for MND treatments

The EXPErimental medicine Route To Success in ALS (EXPERTS-ALS) project aims to rapidly screen potential drugs for evidence that they can slow down damage to the nervous system occurring in people with motor neuron disease

Liver disease drug could help restore cells damaged by Alzheimer’s

A drug which has been used to treat liver disease for decades could help to restore cells damaged by Alzheimer’s, a new study from the University of ΞΆΓάΘ¦ has found.

Revolutionary neck support technology transforms lives of MND patients

A revolutionary neck collar designed to ease pain and make everyday tasks such as eating and communicating much easier for patients living with motor neurone disease (MND) is now available to healthcare professionals and individuals across the world.

Detecting diminished dopamine-firing cells inside the brain could reveal earliest signs of Alzheimer’s disease

A new link between diminished input from dopamine-firing cells deep inside the brain and the ability to form new memories could be crucial in detecting the earliest signs of Alzheimer’s disease.
MRI brain scan

Dopamine-firing cells could reveal early signs of Alzheimer’s disease

A link between diminished input from dopamine-firing cells deep inside the brain and the ability to form new memories could be crucial in detecting the earliest signs of Alzheimer’s disease.